{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/066/ERR12644966/ERR12644966.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/074/ERR12644974/ERR12644974.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/075/ERR12644975/ERR12644975.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/063/ERR12644963/ERR12644963.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/068/ERR12644968/ERR12644968.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/064/ERR12644964/ERR12644964.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/061/ERR12644961/ERR12644961.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/070/ERR12644970/ERR12644970.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/072/ERR12644972/ERR12644972.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/062/ERR12644962/ERR12644962.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/073/ERR12644973/ERR12644973.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/059/ERR12644959/ERR12644959.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/071/ERR12644971/ERR12644971.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/060/ERR12644960/ERR12644960.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/069/ERR12644969/ERR12644969.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/065/ERR12644965/ERR12644965.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/ERR126/067/ERR12644967/ERR12644967.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["European Bioinformatics Institute","Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense, Madrid, Spain Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJEB72409"],"broker_name":["ArrayExpress"],"long_description":["Here we explore the striatum transcriptomic effects of alpha-synuclein administration in mice as model of Parkinson´s disease. Moreover, we also explore the neuroprotective effect of cannabonoid-based druga (VCE-003.2) as a potential neuroportective agent in Parkinson´s disease"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Investigation in the cannabigerol derivative VCE-003.2 as a disease- modifying agent in a mouse model of experimental synucleinopathy","description":"Investigation in the cannabigerol derivative VCE-003.2 as a disease- modifying agent in a mouse model of experimental synucleinopathy","dates":{"last_updated":"2024-11-30","first_public":"2024-11-30"},"accession":"PRJEB72409","cross_references":{}}